Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

First-in-human phase I/Ib clinical trial for FE 999301

Trial Profile

First-in-human phase I/Ib clinical trial for FE 999301

Phase of Trial: Phase I

Latest Information Update: 08 Sep 2016

At a glance

  • Drugs Olamkicept (Primary)
  • Indications Inflammatory bowel diseases; Rheumatoid arthritis
  • Focus Adverse reactions; First in man
  • Most Recent Events

    • 08 Sep 2016 Status changed from planning to completed, according to Conaris Research Institute company pipeline. (http://www.conaris.de/html/pipeline.html)
    • 09 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top